532067 — 3B Blackbio DX Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeSmall CapHigh Flyer

Annual income statement for 3B Blackbio DX, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	R2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	Interim Report	PRESS
Standards:	IAS	IAS	IAS	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	289	2,267	806	618	741
Cost of Revenue
Gross Profit	156	1,752	490	439	523
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	201	774	442	336	422
Operating Profit	87.9	1,494	364	283	319
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	101	1,520	432	353	443
Provision for Income Taxes
Net Income After Taxes	76.9	1,139	322	259	321
Minority Interest
Net Income Before Extraordinary Items
Net Income	76.9	1,139	322	261	327
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	76.9	1,139	322	261	327
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	10.3	152	43	30.3	37.5
Dividends per Share
Special Dividends per Share